{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:01:56Z","timestamp":1789603316662,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Science and Technology Commission of Quzhou Municipality","award":["2024K090"],"award-info":[{"award-number":["2024K090"]}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["82192873, 82171688, 81801411"],"award-info":[{"award-number":["82192873, 82171688, 81801411"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Municipal Health Commission","award":["20204Y0234"],"award-info":[{"award-number":["20204Y0234"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-026-02185-9","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:58:18Z","timestamp":1782712698000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Revisiting ESR in PCOS: an easily obtainable link to immune and metabolic dysregulation"],"prefix":"10.1186","volume":"19","author":[{"given":"Congcong","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Licong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congcong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7125-9608","authenticated-orcid":false,"given":"Jiexue","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"key":"2185_CR1","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1210\/endrev\/bnac001","volume":"43","author":"M Dapas","year":"2022","unstructured":"Dapas M, Dunaif A. Deconstructing a Syndrome: Genomic Insights Into PCOS Causal Mechanisms and Classification. Endocr Rev. 2022;43:927\u201365. https:\/\/doi.org\/10.1210\/endrev\/bnac001.","journal-title":"Endocr Rev"},{"key":"2185_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-024-00511-3","volume":"10","author":"E Stener-Victorin","year":"2024","unstructured":"Stener-Victorin E, Teede H, Norman RJ, Legro R, Goodarzi MO, Dokras A, et al. Polycystic ovary syndrome. Nat Rev Dis Primer. 2024;10:27. https:\/\/doi.org\/10.1038\/s41572-024-00511-3.","journal-title":"Nat Rev Dis Primer"},{"key":"2185_CR3","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s40618-025-02761-8","volume":"49","author":"E Ucgul","year":"2026","unstructured":"Ucgul E, Menekse B, Demirci H, Cakal E. The role of hepatic steatosis Index, fatty liver Index, and metabolic and hormonal biomarkers in differentiating MASLD in polycystic ovary syndrome. J Endocrinol Invest. 2026;49:901\u20139. https:\/\/doi.org\/10.1007\/s40618-025-02761-8.","journal-title":"J Endocrinol Invest"},{"key":"2185_CR4","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.fertnstert.2018.08.021","volume":"110","author":"LG Cooney","year":"2018","unstructured":"Cooney LG, Dokras A. Beyond fertility: polycystic ovary syndrome and long-term health. Fertil Steril. 2018;110:794\u2013809. https:\/\/doi.org\/10.1007\/s40618-025-02761-8.","journal-title":"Fertil Steril"},{"key":"2185_CR5","doi-asserted-by":"publisher","first-page":"bqaf166","DOI":"10.1210\/endocr\/bqaf166","volume":"166","author":"G De Robles","year":"2025","unstructured":"De Robles G, Wiggins KD, Del Mundo Z, Ujagar N, Nguyen CM, Seldin MM, et al. Unpacking PCOS Inflammation: From Misconceptions to Immune Networks. Endocrinology. 2025;166:bqaf166. https:\/\/doi.org\/10.1210\/endocr\/bqaf166.","journal-title":"Endocrinology"},{"key":"2185_CR6","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1210\/clinem\/dgaf524","volume":"111","author":"G Pacheco-Sanchez","year":"2026","unstructured":"Pacheco-Sanchez G, Herrera R, Pisarska MD, Azziz R, Nicholas DA, Chan JL. Multiracial Cytokine Profiling Reveals Immune Dysregulation not Chronic Inflammation in Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2026;111:656\u201364. https:\/\/doi.org\/10.1210\/clinem\/dgaf524.","journal-title":"J Clin Endocrinol Metab"},{"key":"2185_CR7","doi-asserted-by":"publisher","first-page":"110968","DOI":"10.1016\/j.ygeno.2024.110968","volume":"117","author":"Z Yang","year":"2025","unstructured":"Yang Z, Zhou C, Jin L, Pan J. Identification of CCR7 as a potential biomarker in polycystic ovary syndrome through transcriptome sequencing and integrated bioinformatics. Genomics. 2025;117:110968. https:\/\/doi.org\/10.1016\/j.ygeno.2024.110968.","journal-title":"Genomics"},{"key":"2185_CR8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13048-025-01638-x","volume":"18","author":"Y Guo","year":"2025","unstructured":"Guo Y, Yang J, Chen H, Zhou Y, Yang Y, Wang B, et al. Enhancing understanding of endometrial function in patients with PCOS: clinical and immunological insights. J Ovarian Res. 2025;18:52. https:\/\/doi.org\/10.1186\/s13048-025-01638-x.","journal-title":"J Ovarian Res"},{"key":"2185_CR9","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.rbmo.2017.07.010","volume":"35","author":"L Luo","year":"2017","unstructured":"Luo L, Gu F, Jie H, Ding C, Zhao Q, Wang Q, et al. Early miscarriage rate in lean polycystic ovary syndrome women after euploid embryo transfer - a matched-pair study. Reprod Biomed Online. 2017;35:576\u201382. https:\/\/doi.org\/10.1016\/j.rbmo.2017.07.010.","journal-title":"Reprod Biomed Online"},{"key":"2185_CR10","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3109\/09513590.2014.995621","volume":"31","author":"J-X Pan","year":"2015","unstructured":"Pan J-X, Liu Y, Ke Z-H, Zhou C-L, Meng Q, Ding G-L, et al. Successive and cyclic oral contraceptive pill pretreatment improves IVF\/ICSI outcomes of PCOS patients and ameliorates hyperandrogenism and antral follicle excess. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol. 2015;31:332\u20136. https:\/\/doi.org\/10.3109\/09513590.2014.995621.","journal-title":"Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol"},{"key":"2185_CR11","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.fertnstert.2010.11.036","volume":"95","author":"HF Escobar-Morreale","year":"2011","unstructured":"Escobar-Morreale HF, Luque-Ram\u00edrez M, Gonz\u00e1lez F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril. 2011;95:1048\u2013e10581. https:\/\/doi.org\/10.1016\/j.fertnstert.2010.11.036.","journal-title":"Fertil Steril"},{"key":"2185_CR12","doi-asserted-by":"publisher","first-page":"155187","DOI":"10.1016\/j.cyto.2020.155187","volume":"134","author":"JAG Tosatti","year":"2020","unstructured":"Tosatti JAG, S\u00f3ter MO, Ferreira CN, Silva I, de FO, C\u00e2ndido AL, Sousa MO, et al. The hallmark of pro- and anti-inflammatory cytokine ratios in women with polycystic ovary syndrome. Cytokine. 2020;134:155187. https:\/\/doi.org\/10.1016\/j.cyto.2020.155187.","journal-title":"Cytokine"},{"key":"2185_CR13","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0026-0495(99)90100-2","volume":"48","author":"F Gonzalez","year":"1999","unstructured":"Gonzalez F, Thusu K, Abdel-Rahman E, Prabhala A, Tomani M, Dandona P. Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome. Metabolism. 1999;48:437\u201341. https:\/\/doi.org\/10.1016\/s0026-0495(99)90100-2.","journal-title":"Metabolism"},{"key":"2185_CR14","first-page":"317","volume":"115","author":"C Bray","year":"2016","unstructured":"Bray C, Bell LN, Liang H, Haykal R, Kaiksow F, Mazza JJ, et al. Erythrocyte Sedimentation Rate and C-reactive Protein Measurements and Their Relevance in Clinical Medicine. WMJ Off Publ State Med Soc Wis. 2016;115:317\u201321.","journal-title":"WMJ Off Publ State Med Soc Wis"},{"key":"2185_CR15","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/s41416-019-0458-x","volume":"120","author":"J Watson","year":"2019","unstructured":"Watson J, Salisbury C, Banks J, Whiting P, Hamilton W. Predictive value of inflammatory markers for cancer diagnosis in primary care: a prospective cohort study using electronic health records. Br J Cancer. 2019;120:1045\u201351. https:\/\/doi.org\/10.1038\/s41416-019-0458-x.","journal-title":"Br J Cancer"},{"key":"2185_CR16","doi-asserted-by":"publisher","first-page":"ofv098","DOI":"10.1093\/ofid\/ofv098","volume":"2","author":"A Markanday","year":"2015","unstructured":"Markanday A. Acute Phase Reactants in Infections: Evidence-Based Review and a Guide for Clinicians. Open Forum Infect Dis. 2015;2:ofv098. https:\/\/doi.org\/10.1093\/ofid\/ofv098.","journal-title":"Open Forum Infect Dis"},{"key":"2185_CR17","first-page":"297","volume":"13","author":"MA Shearn","year":"1986","unstructured":"Shearn MA, Kang IY. Effect of age and sex on the erythrocyte sedimentation rate. J Rheumatol. 1986;13:297\u20138.","journal-title":"J Rheumatol"},{"key":"2185_CR18","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s00198-003-1501-5","volume":"14","author":"BM Obermayer-Pietsch","year":"2003","unstructured":"Obermayer-Pietsch BM, Lange U, Tauber G, Fr\u00fchauf G, Fahrleitner A, Dobnig H, et al. Vitamin D receptor initiation codon polymorphism, bone density and inflammatory activity of patients with ankylosing spondylitis. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2003;14:995\u20131000. https:\/\/doi.org\/10.1007\/s00198-003-1501-5.","journal-title":"Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"2185_CR19","first-page":"1040","volume":"32","author":"VK Ranganath","year":"2005","unstructured":"Ranganath VK, Elashoff DA, Khanna D, Park G, Peter JB, Paulus HE, et al. Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients. J Rheumatol. 2005;32:1040\u20132.","journal-title":"J Rheumatol"},{"key":"2185_CR20","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1186\/1471-2474-15-368","volume":"15","author":"L Siemons","year":"2014","unstructured":"Siemons L, ten Klooster PM, Vonkeman HE, van Riel PL, Glas CA, van de Laar MA. How age and sex affect the erythrocyte sedimentation rate and C-reactive protein in early rheumatoid arthritis. BMC Musculoskelet Disord. 2014;15:368. https:\/\/doi.org\/10.1186\/1471-2474-15-368.","journal-title":"BMC Musculoskelet Disord"},{"key":"2185_CR21","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s10815-021-02105-4","volume":"38","author":"J Pan","year":"2021","unstructured":"Pan J, Zhou C, Zhou Z, Yang Z, Dai T, Huang H, et al. Elevated ovarian pentraxin 3 in polycystic ovary syndrome. J Assist Reprod Genet. 2021;38:1231\u20137. https:\/\/doi.org\/10.1007\/s10815-021-02105-4.","journal-title":"J Assist Reprod Genet"},{"key":"2185_CR22","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12902-021-00886-4","volume":"21","author":"C Jin","year":"2021","unstructured":"Jin C, Zou K, Xu Y, Yang H, Pan J. Elevated plasma pentraxin-3 in polycystic ovary syndrome is associated with hyperandrogenism: a case-control study. BMC Endocr Disord. 2021;21:240. https:\/\/doi.org\/10.1186\/s12902-021-00886-4.","journal-title":"BMC Endocr Disord"},{"key":"2185_CR23","doi-asserted-by":"publisher","unstructured":"Khan S, Syeda S, Raghuvanshi Y, Shrivastava A. Pathophysiological insights into asprosin: an emerging adipokine in reproductive health. Rev Endocr Metab Disord. 2025. https:\/\/doi.org\/10.1007\/s11154-025-09975-4.","DOI":"10.1007\/s11154-025-09975-4"},{"key":"2185_CR24","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S2213-8587(21)00045-0","volume":"9","author":"X-F Pan","year":"2021","unstructured":"Pan X-F, Wang L, Pan A. Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol Elsevier. 2021;9:373\u201392. https:\/\/doi.org\/10.1016\/S2213-8587(21)00045-0.","journal-title":"Lancet Diabetes Endocrinol Elsevier"},{"key":"2185_CR25","doi-asserted-by":"publisher","unstructured":"Probasco WV, Cefalu C, Lee R, Lee D, Gu A, Dasa V. Prevalence of idiopathically elevated ESR and CRP in patients undergoing primary total knee arthroplasty as a function of body mass index. J Clin Orthop Trauma. 2020;11:S722\u20138. https:\/\/doi.org\/10.1016\/j.jcot.2020.05.03.","DOI":"10.1016\/j.jcot.2020.05.03"},{"key":"2185_CR26","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.1210\/jc.2008-2428","volume":"94","author":"M Bochud","year":"2009","unstructured":"Bochud M, Marquant F, Marques-Vidal P-M, Vollenweider P, Beckmann JS, Mooser V, et al. Association between C-reactive protein and adiposity in women. J Clin Endocrinol Metab. 2009;94:3969\u201377. https:\/\/doi.org\/10.1210\/jc.2008-2428.","journal-title":"J Clin Endocrinol Metab"},{"key":"2185_CR27","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/obr.12003","volume":"14","author":"J Choi","year":"2013","unstructured":"Choi J, Joseph L, Pilote L. Obesity and C-reactive protein in various populations: a systematic review and meta-analysis. Obes Rev Off J Int Assoc Study Obes. 2013;14:232\u201344. https:\/\/doi.org\/10.1111\/obr.12003.","journal-title":"Obes Rev Off J Int Assoc Study Obes"},{"key":"2185_CR28","doi-asserted-by":"publisher","first-page":"108284","DOI":"10.1016\/j.pharmthera.2022.108284","volume":"240","author":"Y Xu","year":"2022","unstructured":"Xu Y, Zhu H, Li W, Chen D, Xu Y, Xu A, et al. Targeting adipokines in polycystic ovary syndrome and related metabolic disorders: from experimental insights to clinical studies. Pharmacol Ther. 2022;240:108284. https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108284.","journal-title":"Pharmacol Ther"},{"key":"2185_CR29","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1042\/CS20201394","volume":"135","author":"D Cardoso","year":"2021","unstructured":"Cardoso D, Perucha E. Cholesterol metabolism: a new molecular switch to control inflammation. Clin Sci. 2021;135:1389\u2013408. https:\/\/doi.org\/10.1042\/CS20201394.","journal-title":"Clin Sci"},{"key":"2185_CR30","doi-asserted-by":"publisher","first-page":"816","DOI":"10.6026\/973206300200816","volume":"20","author":"A Dinakaran","year":"2024","unstructured":"Dinakaran A, AR S, Rajagambeeram R, Nanda SK, Daniel M. SHBG and Insulin resistance - Nexus revisited. Bioinformation. 2024;20:816\u201321. https:\/\/doi.org\/10.6026\/973206300200816.","journal-title":"Bioinformation"},{"key":"2185_CR31","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.tem.2015.05.001","volume":"26","author":"R Sim\u00f3","year":"2015","unstructured":"Sim\u00f3 R, S\u00e1ez-L\u00f3pez C, Barbosa-Desongles A, Hern\u00e1ndez C, Selva DM. Novel insights in SHBG regulation and clinical implications. Trends Endocrinol Metab TEM. 2015;26:376\u201383. https:\/\/doi.org\/10.1016\/j.tem.2015.05.001.","journal-title":"Trends Endocrinol Metab TEM"},{"key":"2185_CR32","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s40618-023-02210-4","volume":"47","author":"F Fruzzetti","year":"2024","unstructured":"Fruzzetti F, Fidecicchi T, Benelli E, Baldari F, Tonacchera M. Body mass index is a good predictor of metabolic abnormalities in polycystic ovary syndrome. J Endocrinol Invest. 2024;47:927\u201336. https:\/\/doi.org\/10.1007\/s40618-023-02210-4.","journal-title":"J Endocrinol Invest"},{"key":"2185_CR33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s13679-023-00531-2","volume":"13","author":"MS Lonardo","year":"2024","unstructured":"Lonardo MS, Cacciapuoti N, Guida B, Di Lorenzo M, Chiurazzi M, Damiano S, et al. Hypothalamic-Ovarian axis and Adiposity Relationship in Polycystic Ovary Syndrome: Physiopathology and Therapeutic Options for the Management of Metabolic and Inflammatory Aspects. Curr Obes Rep. 2024;13:51\u201370. https:\/\/doi.org\/10.1007\/s13679-023-00531-2.","journal-title":"Curr Obes Rep"},{"key":"2185_CR34","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJM199902113400607","volume":"340","author":"C Gabay","year":"1999","unstructured":"Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448\u201354. https:\/\/doi.org\/10.1056\/NEJM199902113400607.","journal-title":"N Engl J Med"},{"key":"2185_CR35","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.lfs.2012.03.019","volume":"90","author":"F Figueroa","year":"2012","unstructured":"Figueroa F, Davicino R, Micalizzi B, Oliveros L, Forneris M. Macrophage secretions modulate the steroidogenesis of polycystic ovary in rats: Effect of testosterone on macrophage pro-inflammatory cytokines. Life Sci. 2012;90:733\u20139. https:\/\/doi.org\/10.1016\/j.lfs.2012.03.019.","journal-title":"Life Sci"},{"key":"2185_CR36","doi-asserted-by":"publisher","first-page":"e230398","DOI":"10.1530\/JOE-23-0398","volume":"261","author":"RJ Ainslie","year":"2024","unstructured":"Ainslie RJ, Simitsidellis I, Kirkwood PM, Gibson DA. RISING STARS: Androgens and immune cell function. J Endocrinol. 2024;261:e230398. https:\/\/doi.org\/10.1530\/JOE-23-0398.","journal-title":"J Endocrinol"},{"key":"2185_CR37","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1113\/JP277756","volume":"597","author":"CW Usselman","year":"2019","unstructured":"Usselman CW, Yarovinsky TO, Steele FE, Leone CA, Taylor HS, Bender JR, et al. Androgens drive microvascular endothelial dysfunction in women with polycystic ovary syndrome: role of the endothelin B receptor. J Physiol. 2019;597:2853\u201365. https:\/\/doi.org\/10.1113\/JP277756.","journal-title":"J Physiol"},{"key":"2185_CR38","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1152\/japplphysiol.00583.2022","volume":"134","author":"DE Berbrier","year":"2023","unstructured":"Berbrier DE, Leone CA, Adler TE, Bender JR, Taylor HS, Stachenfeld NS, et al. Effects of androgen excess and body mass index on endothelial function in women with polycystic ovary syndrome. J Appl Physiol Am Physiological Soc. 2023;134:868\u201378. https:\/\/doi.org\/10.1152\/japplphysiol.00583.2022.","journal-title":"J Appl Physiol Am Physiological Soc"},{"key":"2185_CR39","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s10815-023-02817-9","volume":"40","author":"MF Neblett","year":"2023","unstructured":"Neblett MF, Baumgarten SC, Babayev SN, Shenoy CC. Ovulation induction with letrozole and dexamethasone in infertile patients with letrozole-resistant polycystic ovary syndrome. J Assist Reprod Genet. 2023;40:1461\u20136. https:\/\/doi.org\/10.1007\/s10815-023-02817-9.","journal-title":"J Assist Reprod Genet"},{"key":"2185_CR40","doi-asserted-by":"publisher","first-page":"CD004752","DOI":"10.1002\/14651858.CD004752.pub2","volume":"3","author":"T Kalampokas","year":"2017","unstructured":"Kalampokas T, Pandian Z, Keay SD, Bhattacharya S. Glucocorticoid supplementation during ovarian stimulation for IVF or ICSI. Cochrane Database Syst Rev. 2017;3:CD004752. https:\/\/doi.org\/10.1002\/14651858.CD004752.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"2185_CR41","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1093\/humrep\/del053","volume":"21","author":"A Elnashar","year":"2006","unstructured":"Elnashar A, Abdelmageed E, Fayed M, Sharaf M. Clomiphene citrate and dexamethazone in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective placebo-controlled study. Hum Reprod Oxf Engl. 2006;21:1805\u20138. https:\/\/doi.org\/10.1093\/humrep\/del053.","journal-title":"Hum Reprod Oxf Engl"},{"key":"2185_CR42","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1007\/s10787-024-01504-0","volume":"32","author":"F Fereidouni","year":"2024","unstructured":"Fereidouni F, Kashani L, Amidi F, Khodarahmian M, Zhaeentan S, Ardehjani NA, et al. Astaxanthin treatment decreases pro-inflammatory cytokines and improves reproductive outcomes in patients with polycystic ovary syndrome undergoing assisted reproductive technology: A randomized clinical trial. Inflammopharmacology. 2024;32:2337\u201347. https:\/\/doi.org\/10.1007\/s10787-024-01504-0.","journal-title":"Inflammopharmacology"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-026-02185-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02185-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02185-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:03:40Z","timestamp":1789599820000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13048-026-02185-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2185"],"URL":"https:\/\/doi.org\/10.1186\/s13048-026-02185-9","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"287"}}